Compounds > 1,2-dipalmitoylphosphatidylglycerol
Page last updated: 2024-08-24

1,2-dipalmitoylphosphatidylglycerol and Disease Models, Animal

1,2-dipalmitoylphosphatidylglycerol has been researched along with Disease Models, Animal in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Katsai, OG; Krasnopolskyi, YM; Ruban, OA1
Crance, JM; Crouzier, D; Debouzy, JC; Favier, AL; Garin, D; Perino, J; Spehner, D1
Betbeder, D; Bories, C; De Miguel, I; Imbertie, L; Loiseau, PM1
Curstedt, T; Grossmann, G; Kobayashi, T; Kokubo, M; Robertson, B; Suzuki, Y1

Other Studies

4 other study(ies) available for 1,2-dipalmitoylphosphatidylglycerol and Disease Models, Animal

ArticleYear
Preparation and
    Die Pharmazie, 2017, Dec-01, Volume: 72, Issue:12

    Topics: Animals; Chemistry, Pharmaceutical; Corneal Injuries; Cytochromes c; Disease Models, Animal; Drug Stability; Drug Storage; Emulsions; Excipients; Female; Freeze Drying; Liposomes; Nanoparticles; Osmolar Concentration; Particle Size; Phosphatidylcholines; Phosphatidylglycerols; Phospholipids; Rabbits

2017
Lung surfactant DPPG phospholipid inhibits vaccinia virus infection.
    Antiviral research, 2011, Volume: 89, Issue:1

    Topics: Animals; Antiviral Agents; Cell Line; Cryoelectron Microscopy; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred BALB C; Phosphatidylglycerols; Pulmonary Surfactants; Vaccinia; Vaccinia virus; Virus Attachment; Virus Inactivation

2011
Design and antileishmanial activity of amphotericin B-loaded stable ionic amphiphile biovector formulations.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:5

    Topics: Amphotericin B; Animals; Antiprotozoal Agents; Disease Models, Animal; Drug Carriers; Female; Humans; Leishmania donovani; Leishmaniasis, Visceral; Lipids; Mice; Mice, Inbred BALB C; Phosphatidylglycerols; Polysaccharides

2002
Prolonged ventilation of the premature newborn rabbit after treatment with natural or apoprotein-based artificial surfactant.
    European journal of pediatrics, 1988, Volume: 147, Issue:2

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Apoproteins; Disease Models, Animal; Humans; Infant, Newborn; Lung; Lung Compliance; Phosphatidylglycerols; Pulmonary Alveoli; Pulmonary Surfactants; Rabbits; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Surface-Active Agents

1988